Three Pivotal Drug Policy Organizations Hold Media Briefing/Q&A on DEA Rescheduling of Cannabis
Executives from MAPS, NORML, and MPP to Celebrate DEA Rescheduling of Cannabis to Schedule III Drug and Debunk Myths Executives from MAPS, NORML, and MPP to Celebrate DEA Rescheduling of Cannabis to Schedule III Drug and Debunk Myths
WASHINGTON, May 01, 2024 (GLOBE NEWSWIRE) —
What: The Multidisciplinary Association for Psychedelic Studies (MAPS
), The Marijuana Policy Project (MPP
), and the National Organization for the Re…